Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone Hydrochloride Liposome with Daratumumab and Dexamethasone in R/R Multiple Myeloma
NCT05857982Phase 2Recruiting
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- May 2023
- Primary completion
- Jan 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of mitoxantrone in multiple myeloma (MM), sponsored by The Second Affiliated Hospital of Soochow University. Started May 2023; status: recruiting.
02
Drugs
mitoxantrone
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT05857982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05857982.